These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32209705)

  • 41. Device Cleaning and Infection Control in Aerosol Therapy.
    O'Malley CA
    Respir Care; 2015 Jun; 60(6):917-27; discussion 928-30. PubMed ID: 26070583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
    Jakobsson B; Hjelte L; Nyström B
    J Hosp Infect; 2000 Jan; 44(1):37-41. PubMed ID: 10633052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.
    Retsch-Bogart GZ; Burns JL; Otto KL; Liou TG; McCoy K; Oermann C; Gibson RL;
    Pediatr Pulmonol; 2008 Jan; 43(1):47-58. PubMed ID: 18041081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Disinfection of devices for nebulization: stakes, difficulties, and improvement proposals].
    Reychler G; Dupont C; Dubus JC; ;
    Rev Mal Respir; 2007 Dec; 24(10):1351-61. PubMed ID: 18216754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TOBI: reducing the impact of pseudomonal infection.
    Govan J
    Hosp Med; 2002 Jul; 63(7):421-5. PubMed ID: 12187603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro evaluation of efficacy of 5 methods of disinfection on mouthpieces and facemasks contaminated by strains of cystic fibrosis patients.
    Reychler G; Aarab K; Van Ossel C; Gigi J; Simon A; Leal T; Lebecque P
    J Cyst Fibros; 2005 Sep; 4(3):183-7. PubMed ID: 16046195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outbreak of severe Pseudomonas aeruginosa respiratory infections due to contaminated nebulizers.
    Cobben NA; Drent M; Jonkers M; Wouters EF; Vaneechoutte M; Stobberingh EE
    J Hosp Infect; 1996 May; 33(1):63-70. PubMed ID: 8738203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does repeated disinfection of the e-Flow rapid nebulizer affect in vitro performance?
    Bakuridze L; Andrieu V; Dupont C; Dubus JC
    J Cyst Fibros; 2007 Jul; 6(4):309-10. PubMed ID: 17276148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cystic fibrosis in the modern therapeutic era: Give the shower a thought!
    Le Pennec D; Baravalle-Einaudi M; Dupont C; Vecellio L; Dubus JC;
    J Cyst Fibros; 2019 Nov; 18(6):e56-e57. PubMed ID: 30904464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
    N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preferences and Stated Adherence for Antibiotic Treatment of Cystic Fibrosis Pseudomonas Infections.
    Mohamed AF; Johnson FR; Balp MM; Calado F
    Patient; 2016 Feb; 9(1):59-67. PubMed ID: 25838082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacterial Colonization of Home Nebulizers Used by Children With Recurrent Wheeze.
    Ranjan N; Singla N; Guglani V; Randev S; Kumar P
    Indian Pediatr; 2022 May; 59(5):377-379. PubMed ID: 35348123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of nebulized antibiotics in treating serious respiratory infections.
    Cole PJ
    J Chemother; 2001 Aug; 13(4):354-62. PubMed ID: 11589477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thinking inside the box: nebulizer care, safe storage, and risk of infection in cystic fibrosis.
    Alexander L; Carson J; McCaughan J; Moore JE; Millar BC
    J Bras Pneumol; 2020 Apr; 46(2):e20190226. PubMed ID: 32294716
    [No Abstract]   [Full Text] [Related]  

  • 57. An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis.
    Clifton IJ; Fletcher LA; Beggs CB; Denton M; Conway SP; Peckham DG
    J Cyst Fibros; 2010 Jan; 9(1):64-8. PubMed ID: 19944655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization.
    van Velzen AJ; Bos AC; Touw DJ; Tiddens HA; Heijerman HG; Janssens HM
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):273-80. PubMed ID: 26716357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inadequate Functioning of Nebulizer System Compressors Used by Individuals With Cystic Fibrosis.
    Aquino ES; Vergara AA; Filho LVRFS
    Respir Care; 2021 May; 66(5):829-836. PubMed ID: 33688089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal evaluation of compressor/nebulizer performance.
    Awad S; Williams DK; Berlinski A
    Respir Care; 2014 Jul; 59(7):1053-61. PubMed ID: 24149670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.